Results Snapshot
Quarterly Analysis Highlights - YoY
Net Sales
YoY Growth in quarter ended Dec 2025 is 13.35% vs -6.03% in Dec 2024
Consolidate Net Profit
YoY Growth in quarter ended Dec 2025 is -478.35% vs -541.83% in Dec 2024
Operating Profit (PBDIT) excl Other Income
YoY Growth in quarter ended Dec 2025 is 84.86% vs -273.80% in Dec 2024
Interest
YoY Growth in quarter ended Dec 2025 is 2,725.49% vs -87.48% in Dec 2024
Operating Profit Margin (Excl OI)
YoY Growth in quarter ended Dec 2025 has improved from Dec 2024
Compare Quarterly Results Of Nxera Pharma Co., Ltd. With
Quarterly - Net Sales
QoQ Growth in quarter ended Dec 2025 is 15.00% vs -20.07% in Sep 2025
YoY Growth in quarter ended Dec 2025 is 13.35% vs -6.03% in Dec 2024
Quarterly - Consolidate Net Profit
QoQ Growth in quarter ended Dec 2025 is -361.78% vs 29.66% in Sep 2025
YoY Growth in quarter ended Dec 2025 is -478.35% vs -541.83% in Dec 2024
Quarterly - Operating Profit (PBDIT)
QoQ Growth in quarter ended Dec 2025 is 88.12% vs -1,627.56% in Sep 2025
YoY Growth in quarter ended Dec 2025 is 84.86% vs -273.80% in Dec 2024
Quarterly - Interest
QoQ Growth in quarter ended Dec 2025 is 2,725.49% vs -83.78% in Sep 2025
YoY Growth in quarter ended Dec 2025 is 2,725.49% vs -87.48% in Dec 2024
Quarterly - Operating Profit Margin (Excl OI)
QoQ Growth in quarter ended Dec 2025 has improved from Sep 2025
YoY Growth in quarter ended Dec 2025 has improved from Dec 2024






